Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS) Related Remission: 2-Year Results from a Phase 3 Study

L. Coates, D. Gladman, P. Nash, O. FitzGerald, A. Kavanaugh, L. Rasouliyan, L. Pricop, K. Ding, C. Gaillez
{"title":"Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS) Related Remission: 2-Year Results from a Phase 3 Study","authors":"L. Coates, D. Gladman, P. Nash, O. FitzGerald, A. Kavanaugh, L. Rasouliyan, L. Pricop, K. Ding, C. Gaillez","doi":"10.25251/SKIN.2.SUPP.17","DOIUrl":null,"url":null,"abstract":"Abstract not available. Disclosures:  Study sponsored by Novartis. Copyright 2018 SKIN","PeriodicalId":8405,"journal":{"name":"Arthritis and rheumatism","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthritis and rheumatism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25251/SKIN.2.SUPP.17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract not available. Disclosures:  Study sponsored by Novartis. Copyright 2018 SKIN
Secukinumab实现银屑病关节炎疾病活动评分(PASDAS)相关缓解:来自3期研究的2年结果
摘要不可用。披露:研究由诺华赞助。版权所有2018 SKIN
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Arthritis and rheumatism
Arthritis and rheumatism 医学-风湿病学
自引率
0.00%
发文量
0
审稿时长
1 months
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信